Patients with D2T-PsA can be stratified into inflammatory and noninflammatory phenotypes, with the former linked to higher sonographic activity.

A subset of patients with PsA achieved rapid and sustained remission following treatment with b/tsDMARDs and were classified as a super-responder phenotype.

In adults with early PsA, golimumab with methotrexate and corticosteroids shows no significant difference in improving PsA ...

Patients with PsA have a higher prevalence of MetS compared with members of the general population and individuals with other inflammatory arthropathies.